T1	chemical 10 27	cholinergic drugs
T2	chemical 39 47	nicotine
T3	chemical 68 85	receptor agonists
T4	chemical 94 100	L-dopa
T5	disease_or_phenotypic_feature 155 173	tardive dyskinesia
T6	disease_or_phenotypic_feature 196 215	Tourette's syndrome
T7	disease_or_phenotypic_feature 220 226	ataxia
T8	chemical 244 253	inhibitor
T9	chemical 254 263	sorafenib
T10	disease_or_phenotypic_feature 317 341	hepatocellular carcinoma
T11	disease_or_phenotypic_feature 485 492	obesity
T12	disease_or_phenotypic_feature 497 503	cancer
T13	disease_or_phenotypic_feature 534 541	obesity
T14	chemical 579 586	biology
T15	disease_or_phenotypic_feature 595 617	Cardiovascular disease
T16	chemical 623 632	inhibitor
T17	disease_or_phenotypic_feature 644 657	heart failure
T18	disease_or_phenotypic_feature 684 692	cataract
T19	chemical 713 723	anesthesia
T20	chemical 762 770	antigens
T21	disease_or_phenotypic_feature 799 811	glioblastoma
T22	chemical 844 855	epinephrine
T23	chemical 889 898	halothane
T24	chemical 899 909	anesthesia
T25	disease_or_phenotypic_feature 925 937	cleft palate
T27	chemical 958 969	amphetamine
T28	disease_or_phenotypic_feature 1026 1033	obesity
T29	chemical 1048 1057	biomarker
T30	disease_or_phenotypic_feature 1069 1072	AML
T31	chemical 1177 1187	biomarkers
T32	disease_or_phenotypic_feature 1219 1232	pediatric AML
T33	chemical 1261 1268	biology
T34	disease_or_phenotypic_feature 1294 1301	obesity
T35	disease_or_phenotypic_feature 1322 1329	obesity
T36	disease_or_phenotypic_feature 1331 1349	Tardive dyskinesia
T38	chemical 1447 1455	dopamine
T39	chemical 1456 1476	receptor antagonists
T40	chemical 1503 1517	growth hormone
T41	disease_or_phenotypic_feature 1570 1583	short stature
T42	disease_or_phenotypic_feature 1587 1605	skeletal dysplasia
T43	chemical 1629 1632	dye
T44	chemical 1741 1744	dye
T45	disease_or_phenotypic_feature 1789 1803	gastric cancer
T46	disease_or_phenotypic_feature 1805 1821	Cowden's disease
T47	disease_or_phenotypic_feature 1832 1841	hamartoma
T48	disease_or_phenotypic_feature 1856 1864	syndrome
T49	chemical 1879 1891	isotretinoin
T50	disease_or_phenotypic_feature 1930 1950	renal-cell carcinoma
T51	chemical 2010 2017	hormone
T52	disease_or_phenotypic_feature 2065 2080	prostate cancer
T53	chemical 2190 2193	ZOL
T54	chemical 2197 2205	solution
T55	chemical 2237 2245	solution
T56	disease_or_phenotypic_feature 2249 2257	cataract
T57	disease_or_phenotypic_feature 2258 2267	blindness
T58	chemical 2315 2318	RAS
T59	chemical 2319 2329	inhibitors
T60	disease_or_phenotypic_feature 2419 2439	hypercholesterolemia
T61	disease_or_phenotypic_feature 2441 2449	diabetes
T62	disease_or_phenotypic_feature 2451 2469	metabolic syndrome
T63	disease_or_phenotypic_feature 2474 2481	obesity
T64	chemical 2509 2519	biomarkers
T65	disease_or_phenotypic_feature 2523 2534	lung cancer
T66	chemical 2536 2552	Thyroid hormonal
T67	disease_or_phenotypic_feature 2580 2587	obesity
T68	corrected_chemical 0 27	Nicotinic cholinergic drugs
T69	corrected_chemical 52 85	selective nAChR receptor agonists
T70	missed_disease_or_phenotypic_feature 109 120	dyskinesias
R1	causes_or_contributes_to Arg1:T4 Arg2:T70	
R4	treats Arg1:T69 Arg2:T70	
T73	missed_chemical 133 146	antipsychotic
R5	causes_or_contributes_to Arg1:T73 Arg2:T5	
R6	treats Arg1:T68 Arg2:T5	
R9	treats Arg1:T68 Arg2:T6	
R10	treats Arg1:T2 Arg2:T6	
R12	treats Arg1:T68 Arg2:T7	
R13	treats Arg1:T2 Arg2:T7	
R14	treats Arg1:T69 Arg2:T7	
T74	corrected_chemical 232 263	multikinase inhibitor sorafenib
T75	missed_chemical 265 272	Nexavar
T76	corrected_disease_or_phenotypic_feature 307 312;332 341	renal carcinoma
R15	treats Arg1:T74 Arg2:T76	
R16	treats Arg1:T74 Arg2:T10	
R18	treats Arg1:T75 Arg2:T76	
R19	treats Arg1:T75 Arg2:T10	
T78	corrected_chemical 619 632	BET inhibitor
R21	treats Arg1:T78 Arg2:T17	
T26	corrected_chemical 958 978	amphetamine analogue
R24	treats Arg1:T26 Arg2:T28	
T79	corrected_chemical 1447 1477	dopamine receptor antagonists.
T80	disease_or_phenotypic_feature 1408 1425	movement disorder
R25	causes_or_contributes_to Arg1:T79 Arg2:T36	
R26	causes_or_contributes_to Arg1:T79 Arg2:T80	
T81	corrected_disease_or_phenotypic_feature 1823 1864	multiple hamartoma and neoplasia syndrome
R27	treats Arg1:T49 Arg2:T46	
R28	treats Arg1:T49 Arg2:T81	
T82	missed_chemical 2140 2154	pre-PLCaPZ NPs
R29	treats Arg1:T82 Arg2:T52	
T83	corrected_chemical 2315 2329	RAS inhibitors
T84	missed_chemical 2280 2286	statin
T85	missed_disease_or_phenotypic_feature 2405 2417	hypertension
R31	treats Arg1:T84 Arg2:T60	
R35	treats Arg1:T83 Arg2:T85	
R36	treats Arg1:T83 Arg2:T60	
R37	treats Arg1:T83 Arg2:T61	
R38	treats Arg1:T83 Arg2:T62	
R39	treats Arg1:T83 Arg2:T63	
T86	chemical 939 951	Fenfluramine
R23	treats Arg1:T86 Arg2:T28	
T87	missed_disease_or_phenotypic_feature 2096 2121	reduction of tumor growth
R22	causes_or_contributes_to Arg1:T82 Arg2:T87	
R30	treats Arg1:T84 Arg2:T63	
R32	treats Arg1:T84 Arg2:T62	
R33	treats Arg1:T84 Arg2:T85	
R34	treats Arg1:T84 Arg2:T61	
R2	treats Arg1:T68 Arg2:T70	
R3	treats Arg1:T2 Arg2:T70	
R7	treats Arg1:T2 Arg2:T5	
R8	treats Arg1:T69 Arg2:T6	
R11	treats Arg1:T69 Arg2:T5	
T37	missed_disease_or_phenotypic_feature 354 359	tumor
R17	treats Arg1:T75 Arg2:T37	
R20	treats Arg1:T74 Arg2:T37	
T71	missed_disease_or_phenotypic_feature 399 404	tumor
R40	treats Arg1:T74 Arg2:T71	
R41	treats Arg1:T75 Arg2:T71	
R42	treats Arg1:T78 Arg2:T15	
